Kimberly Jewett Discusses Pathology as Part of the Treatment Process

Article

Kimberly Jewett discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Kimberly Jewett, a two-time breast cancer survivor, president and CEO, Kimberly Jewett Consulting, Inc., discusses how retrieving her pathology report delayed the treatment process. Jewett says pathologists should come out from behind the microscope and engage with patients.

Related Videos
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.